If, SARS-CoV-2 becomes an enduring respiratory pathogen in humans like influenzas or other less-pathogenic coronaviruses (rather than able to be eradicated like SARS-CoV-1), serological diagnosis of acute SARS-CoV-2 infection will depend on IgM detection in post-epidemic areas in subsequent epidemic seasons. This evidence concerns the gene CD40LG and influenza.